Search by Drug Name or NDC
NDC 00143-9180-25 calcium gluconate 98 mg/mL Details
calcium gluconate 98 mg/mL
calcium gluconate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is CALCIUM GLUCONATE MONOHYDRATE.
Product Information
| NDC | 00143-9180 |
|---|---|
| Product ID | 0143-9180_313a4ea9-178b-495e-9bc7-af1860fa6501 |
| Associated GPIs | |
| GCN Sequence Number | 001356 |
| GCN Sequence Number Description | calcium gluconate VIAL 100 MG/ML INTRAVEN |
| HIC3 | C1F |
| HIC3 Description | CALCIUM REPLACEMENT |
| GCN | 03820 |
| HICL Sequence Number | 000585 |
| HICL Sequence Number Description | CALCIUM GLUCONATE |
| Brand/Generic | Generic |
| Proprietary Name | calcium gluconate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | calcium gluconate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 98 |
| Active Ingredient Units | mg/mL |
| Substance Name | CALCIUM GLUCONATE MONOHYDRATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213071 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00143-9180-25 (00143918025)
| NDC Package Code | 0143-9180-25 |
|---|---|
| Billing NDC | 00143918025 |
| Package | 25 VIAL in 1 CARTON (0143-9180-25) / 10 mL in 1 VIAL (0143-9180-01) |
| Marketing Start Date | 2023-10-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |